Oppenheimer Maintains Outperform on Amrize, Lowers Price Target to $52
Benzinga Newsdesk 10 hours ago
Analyst RatingsNewsPrice Target
Oppenheimer analyst Bryan Blair maintains Amrize (NYSE:AMRZ) with a Outperform and lowers the price target from $55 to $52.
Oppenheimer analyst Bryan Blair maintains Amrize (NYSE:AMRZ) with a Outperform and lowers the price target from $55 to $52.